secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001193125-23-039833
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio raises $50M via registered direct offering, issues shares and warrants to institutional investors
--------------------------------------------------------------------------------

- Gross proceeds of ~$50M from sale of 14,072,615 shares and warrants; warrants could yield up to $60M more if fully exercised.
- Purchase price $3.5530 per share with accompanying warrant; warrant exercise price $4.2636, expires in 2 years.
- Jefferies LLC acts as exclusive placement agent; receives 6% cash fee on gross proceeds.
- Proceeds intended for working capital and ongoing business operations.
- Closing expected on or about February 17, 2023, subject to customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523039833/0001193125-23-039833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523039833/d644968d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-039833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer